Evidence map›Paper›PMID 37272726›Full record

ArticlemSystems2023

Carbapenem triggers dissemination of chromosomally integrated carbapenemase genes via conjugative plasmids in

Ryuichiro Abe, Yukihiro Akeda, Yo Sugawara, Yuki Matsumoto, Daisuke Motooka, Tetsuya Iida, Shigeyuki Hamada

Open access · goldAbstract read
In one paragraph

Article in mSystems, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Ryuichiro AbeJapan-Thailand Research Collaboration Center on Emerging and Re-Emerging Infections, Research Institute for Microbial Diseases, Osaka University , Osaka, Japan.ORCID 0000-0001-9907-1180
Yukihiro AkedaJapan-Thailand Research Collaboration Center on Emerging and Re-Emerging Infections, Research Institute for Microbial Diseases, Osaka University , Osaka, Japan.
Yo SugawaraJapan-Thailand Research Collaboration Center on Emerging and Re-Emerging Infections, Research Institute for Microbial Diseases, Osaka University , Osaka, Japan.ORCID 0000-0002-9897-3905
Yuki MatsumotoDepartment of Infection Metagenomics, Research Institute for Microbial Diseases, Osaka University , Osaka, Japan.
Daisuke MotookaDepartment of Infection Metagenomics, Research Institute for Microbial Diseases, Osaka University , Osaka, Japan.
Tetsuya IidaJapan-Thailand Research Collaboration Center on Emerging and Re-Emerging Infections, Research Institute for Microbial Diseases, Osaka University , Osaka, Japan.ORCID 0000-0001-5134-1794
Shigeyuki HamadaJapan-Thailand Research Collaboration Center on Emerging and Re-Emerging Infections, Research Institute for Microbial Diseases, Osaka University , Osaka, Japan.
The University of Osaka · JPNational Institute of Infectious Diseases · JPOsaka International Cancer Institute · JP

Funding

Japan Agency for Medical Research and Development
6 · The paper itself

Abstract

Epidemiological surveys have shown that carbapenem resistance is mainly transmitted across species by carbapenemase genes located on conjugative plasmids. As chromosomal integration of carbapenemase genes has rarely been identified, only a few studies have investigated their advantages to the carbapenem-resistant bacterial community. Here, we confirmed the increased stability of

Indexed as

CarbapenemsEscherichia coliAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesMeropenemPlasmidsAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasescarbapenemaseCarbapenemsMeropenemamplified genesantimicrobial resistance enhancementbacterial communitycarbapenemasecarbapenem resistancechromosomal integrationCREplasmid eliminationplasmid excitationplasmid maintenance

Identifiers

PMID37272726
PMCPMC10308940
OpenAlexW4379375504

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.